NewGenIVF Group Limited filed a Form 6-K with the SEC on November 17, 2026, furnishing an update on its non-affiliate Class A ordinary shares and outstanding convertible notes as of that date.

Key Highlights

  • Class A Ordinary Shares outstanding: 2,790,883 as of November 17, 2026, according to the Continental Stock Transfer & Trust Company report.
  • Class B Ordinary Shares outstanding: 9,136 as of November 17, 2026.
  • Non-affiliate Class A shares: 2,752,036 of the total Class A shares were held by non-affiliates.
  • Aggregate convertible note principal: US$2,044,373 in outstanding convertible notes as of November 17, 2026.
  • Eligible for conversion: Only US$323,812 of the convertible notes (those outstanding more than 180 days) is currently eligible for conversion.
  • Remaining notes restricted: The balance of the convertible notes "remain subject to escrow or Rule 144 restrictions and are not freely convertible at this time," according to the filing.

NewGenIVF Group Provides Share Count and Convertible Note Status

NewGenIVF Group Limited (NASDAQ:NIVF) filed a Form 6-K for the month of November 2026, furnishing updated information on its share structure and convertible note obligations. The filing identified the CUSIP for the Company's shares as G6544E162 / A610ORD and cited data from the Continental Stock Transfer & Trust Company. As of November 17, 2026, total shares outstanding comprised 2,790,883 Class A Ordinary Shares and 9,136 Class B Ordinary Shares. Of the Class A shares, 2,752,036 were reported as held by non-affiliates.

Regarding the Company's convertible notes, the filing disclosed an aggregate principal amount of US$2,044,373 outstanding as of the same date. The Company noted that only US$323,812 of that total, specifically the notes that have been outstanding more than 180 days, is currently eligible for conversion. The filing stated that the remaining notes are subject to escrow or Rule 144 restrictions and are not freely convertible.

The filing was signed by Wing Fung Alfred Siu, Chairman of the Board and Director, on November 17, 2026. The Company stated the information "is being furnished solely for the convenience of investors and does not constitute an offer to sell or a solicitation of an offer to buy any securities."

What Was Disclosed

NewGenIVF Group Limited furnished a Form 6-K disclosing its share counts as of November 17, 2026, including 2,752,036 non-affiliate Class A shares, and reporting US$2,044,373 in outstanding convertible notes, of which US$323,812 is currently eligible for conversion.